Women ≥30 years of age with low grade squamous intraepithelial lesion (LSIL) have low positivity rates when cotested for high-risk human papillomavirus: Should we reconsider HPV triage for LSIL in older women?

Diagnostic Cytopathology

Volumn 38, Issue 6, 2010, Pages 407-412

  Thrall, Michael J ^a   Smith, Debora A ^a   Mody, Dina R ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Cervical intraepithelial neoplasia; Colposcopy; Human papillomavirus; Low grade squamous intraepithelial lesion; Papanicolaou test

Indexed keywords

ADULT; ARTICLE; CANCER RISK; COLPOSCOPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; AGE; AGE DISTRIBUTION; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PRECANCER; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

ADULT; AGE DISTRIBUTION; AGE FACTORS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 77952846702     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21209     Document Type: Article

References (17)

1. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;197:346-355.
2. Wright TC, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304-309.
3. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299. (Pubitemid 32219816)
4. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial. J Natl Cancer Inst 2000;92: 397-402.
5. Schiffman M, Adrianza ME. ASCUS-LSIL triage Study. Design, methods and characteristics of trial participants. Acta Cytol 2000; 44:726-742.
6. VassarStats. Available at faculty.vassar.edu/lowry/VassarStats.html.
7. Sherman M, Schiffman M, Cox J. Effects of age and human papilloma viral load on colposcopy triage: Data from the randomized atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study (ALTS). J Natl Cancer Inst 2002;94:102-107. (Pubitemid 34121289)
8. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-1400.
9. Moriarty A, Schwartz M, Eversole G, et al. Human papillomavirus testing and reporting rates: Practices of participants in the College of American Pathologists interlaboratory comparison program in gynecologic cytology in 2006. Arch Pathol Lab Med 2008;132:1290-1294.
10. Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006;119:2677-2684. (Pubitemid 44691325)
11. Datta SD, Koutsky LA, Ratelle S, et al. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med 2008;148: 493-500.
12. Baseman J, Kulasingam S, Harris T, et al. Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States. Am J Obstet Gynecol 2008;199:26.e1-26.e8.
13. Moss S, Gray A, Legood R, Vessey M, Patnick J, Kitchener H. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: Observational before and after study. BMJ 2006;332:83-85. (Pubitemid 43099248)
14. Fröberg M, Johansson B, Hjerpe A, Andersson S. Human papillomavirus 'reflex' testing as a screening method in cases of minor cytological abnormalities. Br J Cancer 2008;99:563-568.
15. Ronco G, Segnan N, Giorgi-Rossi P, et al. Human papillomavirus and liquid-based cytology: Results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 2006;98:765-774. (Pubitemid 43983300)
16. Ronco G, Cuzick J, Segnan N, et al. HPV triage for low grade (LSIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur J Cancer 2007; 43:476-480. (Pubitemid 46177594)
17. Kurman RJ, Solomon D, Nayar R, Davey DD, Wilbur DC. The Bethesda system for reporting cervical cytology: Definitions, criteria, and explanatory notes. New York: Springer; 2003.